合計 50 件の最近のインサイダー取引記録が記録されています Achison Inc. (ACHN), 内訳は 30 件の買い および 20 件の売り. インサイダー買い総額は $17.71M インサイダー売り総額は $4.77M.
最近活動のある主要インサイダーには New Living Ventures Llc, Manning Martha E, Kishbauch Michael D. インサイダー取引記録は、経営陣が株式の評価と将来の見通しをどう見ているかについての洞察を提供します.
インサイダー取引記録 — ACHN
| 日付 |
氏名 |
役職 |
取引種別 |
株数 |
平均価格 |
価値 |
保有株数 |
| 2023-04-10 |
New Living Ventures Llc |
10 Percent Owner |
処分 |
- |
- |
- |
29,215,000 |
| 2020-01-29 |
Manning Martha E |
General Counsel |
株式返還 |
135,000 |
$4.11 |
$554.85K |
- |
| 2020-01-28 |
Kishbauch Michael D |
Director |
株式返還 |
30,000 |
$7.54 |
$226.2K |
- |
| 2020-01-28 |
Vitullo Nicole |
Director |
株式返還 |
42,000 |
$2.18 |
$91.56K |
- |
| 2020-01-28 |
Fisherman Jason S |
Director |
株式返還 |
42,000 |
$2.18 |
$91.56K |
- |
| 2020-01-28 |
Van Nostrand Robert L |
Director |
株式返還 |
42,000 |
$2.18 |
$91.56K |
- |
| 2020-01-28 |
Manning Martha E |
General Counsel |
株式返還 |
2,500 |
$6.30 |
$15.75K |
- |
| 2020-01-28 |
Truitt Joseph |
Chief Executive Officer |
株式返還 |
1,097,000 |
$2.18 |
$2.39M |
- |
| 2020-01-28 |
Verwiel Frank |
Director |
株式返還 |
42,000 |
$2.18 |
$91.56K |
- |
| 2020-01-28 |
Zelenkofske Steven |
EVP, Chief Medical Officer |
株式返還 |
200,000 |
$2.18 |
$436K |
- |
| 2020-01-28 |
Firuta Paul E |
EVP, Chief Commercial Officer |
株式返還 |
200,000 |
$2.18 |
$436K |
- |
| 2019-12-18 |
Van Nostrand Robert L |
Director |
オプション行使（売却） |
20,000 |
$3.28 |
$65.6K |
- |
| 2019-11-14 |
Fisherman Jason S |
Director |
オプション行使（売却） |
20,000 |
$3.28 |
$65.6K |
- |
| 2019-10-16 |
Truitt Joseph |
Chief Executive Officer |
オプション行使（売却） |
33,250 |
$3.28 |
$109.06K |
- |
| 2019-01-23 |
Kishbauch Michael D |
Director |
RSU 付与（制限付株式） |
42,000 |
$2.18 |
$91.56K |
42,000 |
| 2019-01-23 |
Vitullo Nicole |
Director |
RSU 付与（制限付株式） |
42,000 |
$2.18 |
$91.56K |
42,000 |
| 2019-01-23 |
Fisherman Jason S |
Director |
RSU 付与（制限付株式） |
42,000 |
$2.18 |
$91.56K |
42,000 |
| 2019-01-23 |
Van Nostrand Robert L |
Director |
RSU 付与（制限付株式） |
42,000 |
$2.18 |
$91.56K |
42,000 |
| 2019-01-23 |
Manning Martha E |
General Counsel |
RSU 付与（制限付株式） |
150,000 |
$2.18 |
$327K |
150,000 |
| 2019-01-23 |
Truitt Joseph |
Chief Executive Officer |
RSU 付与（制限付株式） |
1,097,000 |
$2.18 |
$2.39M |
1,097,000 |
| 2019-01-23 |
Verwiel Frank |
Director |
RSU 付与（制限付株式） |
42,000 |
$2.18 |
$91.56K |
42,000 |
| 2019-01-23 |
Zelenkofske Steven |
Chief Medical Officer |
RSU 付与（制限付株式） |
200,000 |
$2.18 |
$436K |
200,000 |
| 2019-01-23 |
Firuta Paul E |
Chief Operating Officer |
RSU 付与（制限付株式） |
200,000 |
$2.18 |
$436K |
200,000 |
| 2018-12-14 |
Van Nostrand Robert L |
Director |
オプション行使（売却） |
20,000 |
$1.05 |
$21K |
- |
| 2018-09-11 |
Firuta Paul E |
Chief Operating Officer |
RSU 付与（制限付株式） |
400,000 |
$3.32 |
$1.33M |
400,000 |
| 2018-09-10 |
Firuta Paul E |
Chief Operating Officer |
処分 |
- |
- |
- |
- |
| 2018-08-20 |
Zelenkofske Steven |
Chief Medical Officer |
処分 |
- |
- |
- |
- |
| 2018-08-20 |
Zelenkofske Steven |
Chief Medical Officer |
RSU 付与（制限付株式） |
500,000 |
$2.49 |
$1.25M |
500,000 |
| 2018-06-06 |
Fisherman Jason S |
Director |
オプション行使（売却） |
20,000 |
$1.05 |
$21K |
- |
| 2018-05-31 |
Vitullo Nicole |
Director |
その他（売り） |
25,000 |
- |
- |
- |
| 2018-05-01 |
Truitt Joseph |
Chief Executive Officer |
RSU 付与（制限付株式） |
632,000 |
$3.78 |
$2.39M |
632,000 |
| 2018-02-09 |
Kishbauch Michael D |
Director |
RSU 付与（制限付株式） |
30,000 |
$2.90 |
$87K |
30,000 |
| 2018-02-09 |
Vitullo Nicole |
Director |
RSU 付与（制限付株式） |
30,000 |
$2.90 |
$87K |
30,000 |
| 2018-02-09 |
Fisherman Jason S |
Director |
RSU 付与（制限付株式） |
30,000 |
$2.90 |
$87K |
30,000 |
| 2018-02-09 |
Van Nostrand Robert L |
Director |
RSU 付与（制限付株式） |
30,000 |
$2.90 |
$87K |
30,000 |
| 2018-02-09 |
Manning Martha E |
General Counsel |
RSU 付与（制限付株式） |
215,000 |
$2.90 |
$623.5K |
215,000 |
| 2018-02-09 |
Deshpande Milind |
Chief Executive Officer |
RSU 付与（制限付株式） |
640,000 |
$2.90 |
$1.86M |
640,000 |
| 2018-02-09 |
Truitt Joseph |
Chief Commercial Officer |
RSU 付与（制限付株式） |
419,000 |
$2.90 |
$1.22M |
419,000 |
| 2018-02-09 |
Verwiel Frank |
Director |
RSU 付与（制限付株式） |
30,000 |
$2.90 |
$87K |
30,000 |
| 2017-08-10 |
Vitullo Nicole |
Director |
オプション行使（売却） |
20,706 |
$3.11 |
$64.45K |
- |
| 2017-06-28 |
Fisherman Jason S |
Director |
相続（買い） |
1,500 |
- |
- |
1,500 |
| 2017-01-19 |
Kishbauch Michael D |
Director |
RSU 付与（制限付株式） |
30,000 |
$4.09 |
$122.7K |
30,000 |
| 2017-01-19 |
Vitullo Nicole |
Director |
RSU 付与（制限付株式） |
30,000 |
$4.09 |
$122.7K |
30,000 |
| 2017-01-19 |
Fisherman Jason S |
Director |
RSU 付与（制限付株式） |
30,000 |
$4.09 |
$122.7K |
30,000 |
| 2017-01-19 |
Van Nostrand Robert L |
Director |
RSU 付与（制限付株式） |
30,000 |
$4.09 |
$122.7K |
30,000 |
| 2017-01-19 |
Verwiel Frank |
Director |
RSU 付与（制限付株式） |
30,000 |
$4.09 |
$122.7K |
30,000 |
| 2017-01-17 |
Manning Martha E |
EVP, General Counsel |
RSU 付与（制限付株式） |
135,000 |
$4.11 |
$554.85K |
135,000 |
| 2017-01-17 |
Deshpande Milind |
Chief Executive Officer |
RSU 付与（制限付株式） |
458,000 |
$4.11 |
$1.88M |
458,000 |
| 2017-01-17 |
Truitt Joseph |
Chief Commercial Officer |
RSU 付与（制限付株式） |
185,000 |
$4.11 |
$760.35K |
185,000 |
| 2017-01-17 |
Apelian David |
Chief Medical Officer |
RSU 付与（制限付株式） |
185,000 |
$4.11 |
$760.35K |
185,000 |
■ 情報付き — 公開市場取引（最も重要）
■ 情報なし（買い） — 報酬・オプション行使・転換
■ 情報なし（売り） — 源泉徴収・付与売却
■ 中立 — 贈与・信託・失効
